Key result
Intensive blood pressure lowering to normal levels in centrally obese diabetic patients did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events.
Why the study?
Does intensive blood pressure treatment reduce the combined risk of fatal or nonfatal cardiovascular disease events in centrally obese hypertensive adults with Type 2 diabetes?
Does intensive blood pressure treatment reduce the combined risk of fatal or nonfatal cardiovascular disease events in centrally obese hypertensive adults with Type 2 diabetes?
While intensive blood pressure control does not appear to reduce overall cardiovascular events in centrally obese patients with Type 2 diabetes, it may offer specific benefits for stroke prevention.
Intensive BP lowering may not benefit centrally obese diabetics with hypertension; leaves open optimal targets for this subgroup.
Evaluation of: Barzilay JI, Howard AG, Evans GW et al. Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Diabetes Care 35(7), 1401–1405 (2012).In the ACCORD clinical trial, lowering blood pressure (BP) to normal levels, below currently recommended levels, did not significantly reduce the combined risk of fatal or nonfatal cardiovascular (CV) disease events in adults with Type 2 diabetes. A new post hoc analysis of the same trial also suggests that lowering BP in centrally obese diabetic patients is not a useful means for CV prevention. The authors discuss these findings in the light of accumulated evidence on the relationship between the degree of BP reduction and the risk of CV events in patients with diabetes. In particular, the authors focus on trial and systematic review findings, suggesting that a more intensive reduction of BP in Type 2 diabetes effectively protects from stroke.
No takes yet. Share an insight, caveat, or question.
Angeli et al. (2012) conducted an editorial in Type 2 diabetes with central obesity and hypertension. Intensive blood pressure lowering was evaluated on Combined risk of fatal or nonfatal cardiovascular disease events. Intensive blood pressure lowering to normal levels in centrally obese diabetic patients did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: